Cargando…
Prescription Practices in Patients With Mild to Moderate CKD in India
INTRODUCTION: Patients with chronic kidney disease (CKD) require multiple medications. There is no information on prescription patterns or the use of evidence-based therapies for management of CKD from low-middle-income countries. Using baseline data from the Indian CKD (ICKD) cohort, we describe th...
Autores principales: | Prasad, Narayan, Yadav, Ashok Kumar, Kundu, Monica, Sethi, Jasmin, Jaryal, Ajay, Sircar, Dipankar, Modi, Gopesh K., Kamboj, Kajal, Sahay, Manisha, Gopalakrishnan, Natarajan, Kaur, Prabhjot, Vikrant, Sanjay, Varughese, Santosh, Baid-Agrawal, Seema, Singh, Shivendra, Gang, Sishir, Parameswaran, Sreejith, Kumar, Vivek, Ghosh, Arpita, Jha, Vivekanand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418981/ https://www.ncbi.nlm.nih.gov/pubmed/34514206 http://dx.doi.org/10.1016/j.ekir.2021.06.011 |
Ejemplares similares
-
Renin-angiotensin blocker use is associated with improved cardiovascular mortality in Indian patients with mild-moderate chronic kidney disease—findings from the ICKD study
por: Prasad, Narayan, et al.
Publicado: (2022) -
The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics
por: Kumar, Vivek, et al.
Publicado: (2021) -
A randomized trial of once daily versus twice daily dosing of oral iron in CKD
por: Sood, Vivek, et al.
Publicado: (2023) -
Serum myo-inositol oxygenase levels at hospital discharge predict progression to chronic kidney disease in community-acquired acute kidney injury
por: Kakkanattu, Tom Jose, et al.
Publicado: (2022) -
Cholecalciferol supplementation and angiogenic markers in chronic kidney disease
por: Kaur, Jaskiran, et al.
Publicado: (2022)